Last reviewed · How we verify

Silver Sulphadiazine Ag cream

Molnlycke Health Care AB · Phase 1 active Small molecule

Silver Sulphadiazine Ag cream is a Small molecule drug developed by Molnlycke Health Care AB. It is currently in Phase 1 development. Also known as: SSD Ag cream, 1% SSD Ag, 40g/tube.

At a glance

Generic nameSilver Sulphadiazine Ag cream
Also known asSSD Ag cream, 1% SSD Ag, 40g/tube
SponsorMolnlycke Health Care AB
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Silver Sulphadiazine Ag cream

What is Silver Sulphadiazine Ag cream?

Silver Sulphadiazine Ag cream is a Small molecule drug developed by Molnlycke Health Care AB.

Who makes Silver Sulphadiazine Ag cream?

Silver Sulphadiazine Ag cream is developed by Molnlycke Health Care AB (see full Molnlycke Health Care AB pipeline at /company/molnlycke-health-care-ab).

Is Silver Sulphadiazine Ag cream also known as anything else?

Silver Sulphadiazine Ag cream is also known as SSD Ag cream, 1% SSD Ag, 40g/tube.

What development phase is Silver Sulphadiazine Ag cream in?

Silver Sulphadiazine Ag cream is in Phase 1.

Related